JERUSALEM and NEW YORK – TEVA Pharmaceutical Industries and Mount Sinai Health System are partnering to create scalable solutions to improve care for people with multiple chronic conditions.
“While the personal challenges may differ, the mental, social and financial strain of multiple chronic conditions on patients and their families is universal,” said Iris Beck Codner, group executive vice president of Teva Pharmaceuticals, in a statement. “We hope this effort will shed light on the unique pressures weighing on patients and the potential for centering treatment on the patient versus individual conditions to help them live better and longer lives.”
The partnership will create a regional pilot program that will gain new data and insights into interventions for people with multiple chronic conditions. Potential areas for exploration in the partnership include: technology-based solutions like telemedicine, remote monitoring and cognitive computing; cross condition management; and medication regimen simplification, including digital compliance technology.